Akari Therapeutics Plc - American Depositary Shares —— 资产负债表 (NASDAQ:AKTX) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 14.6 M11.65 M13.83 M4.36 M50.56 M47.89 M 负债总额 5.22 M6.09 M12.04 M4.58 M28.33 M19.56 M 权益总额 9.38 M5.55 M1.79 M-229 K22.23 M28.33 M 负债及股东权益总额 14.6 M11.65 M13.83 M4.36 M50.56 M47.89 M 总债务 ————1.36 M754 K 净债务 ————-1.24 M754 K

新闻

Upcoming Stock Splits This Week (March 30 to April 2) – Stay Invested - TipRanks.com

Akari Therapeutics首席执行官Gaslightwala上任满一年

Akari Therapeutics marks one year under CEO Gaslightwala

Akari Therapeutics任命RNA剪接专家加入顾问委员会

Akari Therapeutics adds RNA splicing expert to advisory board

Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Antelope Ent Hldgs (NASDAQ:AEHL), Aimei Health Technology (NASDAQ:AFJK)

Akari Therapeutics推进ADC肿瘤项目，开发新型药物载荷

Akari Therapeutics advances ADC oncology program with novel payload

Akari与WuXi XDC启动主要ADC项目GMP生产

Akari begins GMP manufacturing of lead ADC program with WuXi XDC

Akari Therapeutics通过场内发行筹集500万美元

Akari Therapeutics raises $5 million in at-market offering